DE60009912D1 - Verfahren zur rnase- und organische lösemitteln-freier reinigung von plasmid-dns durch tangentialfluss-filtration - Google Patents
Verfahren zur rnase- und organische lösemitteln-freier reinigung von plasmid-dns durch tangentialfluss-filtrationInfo
- Publication number
- DE60009912D1 DE60009912D1 DE60009912T DE60009912T DE60009912D1 DE 60009912 D1 DE60009912 D1 DE 60009912D1 DE 60009912 T DE60009912 T DE 60009912T DE 60009912 T DE60009912 T DE 60009912T DE 60009912 D1 DE60009912 D1 DE 60009912D1
- Authority
- DE
- Germany
- Prior art keywords
- plasmid dna
- flow filtration
- tangential flow
- rnase
- organic solvent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1003—Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor
- C12N15/1017—Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor by filtration, e.g. using filters, frits, membranes
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S977/00—Nanotechnology
- Y10S977/84—Manufacture, treatment, or detection of nanostructure
- Y10S977/894—Manufacture, treatment, or detection of nanostructure having step or means utilizing biological growth
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S977/00—Nanotechnology
- Y10S977/84—Manufacture, treatment, or detection of nanostructure
- Y10S977/895—Manufacture, treatment, or detection of nanostructure having step or means utilizing chemical property
- Y10S977/896—Chemical synthesis, e.g. chemical bonding or breaking
- Y10S977/898—Enzymatic
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S977/00—Nanotechnology
- Y10S977/902—Specified use of nanostructure
- Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
- Y10S977/908—Mechanical repair performed/surgical
- Y10S977/91—Strengthening cell or tissue
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S977/00—Nanotechnology
- Y10S977/902—Specified use of nanostructure
- Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
- Y10S977/908—Mechanical repair performed/surgical
- Y10S977/912—Cancer cell repair
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S977/00—Nanotechnology
- Y10S977/902—Specified use of nanostructure
- Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
- Y10S977/914—Protein engineering
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S977/00—Nanotechnology
- Y10S977/902—Specified use of nanostructure
- Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
- Y10S977/924—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis using nanostructure as support of dna analysis
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US14531699P | 1999-07-23 | 1999-07-23 | |
US145316P | 1999-07-23 | ||
US16520699P | 1999-11-12 | 1999-11-12 | |
US165206P | 1999-11-12 | ||
PCT/US2000/019963 WO2001007599A1 (en) | 1999-07-23 | 2000-07-21 | Method for rnase- and organic solvent-free plasmid dna purification using tangential flow filtration |
Publications (2)
Publication Number | Publication Date |
---|---|
DE60009912D1 true DE60009912D1 (de) | 2004-05-19 |
DE60009912T2 DE60009912T2 (de) | 2005-04-14 |
Family
ID=26842848
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE60009912T Expired - Fee Related DE60009912T2 (de) | 1999-07-23 | 2000-07-21 | Verfahren zur rnase- und organische lösemitteln-freier reinigung von plasmid-dns durch tangentialfluss-filtration |
Country Status (18)
Country | Link |
---|---|
US (1) | US6313285B1 (de) |
EP (1) | EP1200578B1 (de) |
JP (1) | JP2003505077A (de) |
KR (1) | KR100669305B1 (de) |
CN (1) | CN1378592A (de) |
AT (1) | ATE264386T1 (de) |
BR (1) | BR0012627A (de) |
CA (1) | CA2378944A1 (de) |
DE (1) | DE60009912T2 (de) |
DK (1) | DK1200578T3 (de) |
ES (1) | ES2218185T3 (de) |
HK (1) | HK1048829A1 (de) |
HU (1) | HUP0202295A3 (de) |
IL (1) | IL147644A0 (de) |
NZ (1) | NZ516641A (de) |
PL (1) | PL364816A1 (de) |
PT (1) | PT1200578E (de) |
WO (1) | WO2001007599A1 (de) |
Families Citing this family (38)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6602414B2 (en) * | 2000-03-30 | 2003-08-05 | Formulations Pro | Molecule separation device and method combining multiple filtration media |
WO2002024232A2 (en) * | 2000-09-25 | 2002-03-28 | Board Of Regents, The University Of Texas System | Pei: dna vector formulations for in vitro and in vivo gene delivery |
US6995246B1 (en) * | 2000-10-19 | 2006-02-07 | Akzo Nobel N.V. | Methods for removing suspended particles from soluble protein solutions |
GB0028361D0 (en) * | 2000-11-21 | 2001-01-03 | Glaxo Group Ltd | Method of separating extra chromosomal dna from other cellular components |
JP3547715B2 (ja) * | 2001-03-06 | 2004-07-28 | 榮 新垣 | ベクター精製用装置及び方法 |
GB0107634D0 (en) * | 2001-03-27 | 2001-05-16 | Fermentas Ab | Nucleic acid purification |
DE60330842D1 (de) | 2002-01-28 | 2010-02-25 | Ambion Inc | Für den nachweis von nukleinsäuren kompetente biologische rohderivate |
AU2003267175A1 (en) * | 2002-09-13 | 2004-04-30 | Valentis, Inc. | Apparatus and method for preparative scale purification of nucleic acids |
US8501402B2 (en) | 2003-03-24 | 2013-08-06 | Boehringer Ingelheim Rcv Gmbh & Co Kg | Methods and devices for producing biomolecules |
CN1283792C (zh) | 2003-11-14 | 2006-11-08 | 余伟明 | 生物大分子组分相分离法 |
US7790039B2 (en) * | 2003-11-24 | 2010-09-07 | Northwest Biotherapeutics, Inc. | Tangential flow filtration devices and methods for stem cell enrichment |
SE0400490D0 (sv) | 2004-02-26 | 2004-02-26 | Amersham Biosciences Ab | Plasmid purification |
CA2595594C (en) * | 2005-01-31 | 2012-05-01 | Merck & Co., Inc. | Upstream and a downstream purification process for large scale production of plasmid dna |
US20080113357A1 (en) * | 2006-06-29 | 2008-05-15 | Millipore Corporation | Filter device for the isolation of a nucleic acid |
US7964350B1 (en) * | 2007-05-18 | 2011-06-21 | Applied Biosystems, Llc | Sample preparation for in situ nucleic acid analysis |
WO2008150826A1 (en) * | 2007-05-31 | 2008-12-11 | Ge Healthcare Uk Limited | Modified spin column for simple and rapid plasmid dna extraction |
EP2088196A1 (de) | 2008-02-08 | 2009-08-12 | Boehringer Ingelheim RCV GmbH & Co KG | Verfahren und Vorrichtungen zur Herstellung von Biomolekülen |
WO2009129524A2 (en) * | 2008-04-18 | 2009-10-22 | The General Hospital Corporation | High-throughput plasmid dna preparation |
TWI469992B (zh) * | 2008-08-28 | 2015-01-21 | Baxter Int | 濃縮剪切靈敏生物聚合物的方法 |
WO2010071833A1 (en) | 2008-12-19 | 2010-06-24 | Life Technologies Corporation | Proteinase k inhibitors, methods and compositions therefor |
PL3338765T3 (pl) | 2009-12-01 | 2019-06-28 | Translate Bio, Inc. | Pochodna steroidowa dla dostarczania mrna w ludzkich chorobach genetycznych |
SG192027A1 (en) | 2011-04-01 | 2013-08-30 | Emd Millipore Corp | Nanofiber containing composite structures |
KR20220025112A (ko) | 2011-06-08 | 2022-03-03 | 샤이어 휴먼 지네틱 테라피즈 인크. | Mrna 전달을 위한 지질 나노입자 조성물 및 방법 |
US20150267192A1 (en) | 2012-06-08 | 2015-09-24 | Shire Human Genetic Therapies, Inc. | Nuclease resistant polynucleotides and uses thereof |
CA2904151C (en) | 2013-03-14 | 2023-09-12 | Shire Human Genetic Therapies, Inc. | Cftr mrna compositions and related methods and uses |
DK2970955T3 (en) | 2013-03-14 | 2019-02-11 | Translate Bio Inc | METHODS FOR CLEANING MESSENGER RNA |
CN103525866A (zh) * | 2013-03-22 | 2014-01-22 | 人福医药集团股份公司 | 制备质粒的方法 |
EP3060258A1 (de) | 2013-10-22 | 2016-08-31 | Shire Human Genetic Therapies, Inc. | Mrna-therapie für phenylketonurie |
EP4276176A3 (de) | 2013-10-22 | 2024-01-10 | Translate Bio, Inc. | Mrna-therapie für argininosuccinat-synthase-mangel |
DK178664B1 (en) * | 2013-10-25 | 2016-10-24 | Amphi Consult V Martin Hesselsøe Aps | A system and a method for concentrating traces of tissue from aquatic organisms in a water sample and use thereof |
ES2787174T3 (es) | 2013-12-18 | 2020-10-15 | Asahi Chemical Ind | Procedimiento para detectar bacterias coliformes contenidas en la leche |
MX2016013965A (es) | 2014-04-25 | 2017-01-09 | Shire Human Genetic Therapies | Metodos de purificacion de arn mensajero. |
KR102206963B1 (ko) | 2015-04-17 | 2021-01-25 | 이엠디 밀리포어 코포레이션 | 접선방향 유동 여과 모드에서 작동되는 나노섬유 한외여과막을 사용하여 샘플에서 목적하는 생물학적 물질을 정제하는 방법 |
EP3294885B1 (de) | 2015-05-08 | 2020-07-01 | CureVac Real Estate GmbH | Verfahren zur herstellung von rna |
DK3303583T3 (da) | 2015-05-29 | 2020-07-13 | Curevac Real Estate Gmbh | Fremgangsmåde til fremstilling og oprensning af rna, omfattende mindst et trin til tangential-flow-filtrering |
WO2018157154A2 (en) | 2017-02-27 | 2018-08-30 | Translate Bio, Inc. | Novel codon-optimized cftr mrna |
IL270631B2 (en) | 2017-05-16 | 2024-03-01 | Translate Bio Inc | Treatment of cystic fibrosis through the administration of mRNA with an optimal codon encoding ctfr |
EP3841208A1 (de) | 2018-08-24 | 2021-06-30 | Translate Bio, Inc. | Verfahren zur reinigung von messenger-rna |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3128669A1 (de) * | 1981-07-20 | 1983-02-03 | Hoechst Ag, 6000 Frankfurt | "plasmid p svh 1 und seine verwendung" |
GB8600582D0 (en) | 1986-01-10 | 1986-02-19 | Ca Minister Nat Defence | Purifying biological materials |
AU605901B2 (en) | 1987-09-11 | 1991-01-24 | Ares Trading S.A. | Purification process |
US5256294A (en) | 1990-09-17 | 1993-10-26 | Genentech, Inc. | Tangential flow filtration process and apparatus |
ES2227557T3 (es) * | 1994-07-15 | 2005-04-01 | MERCK & CO., INC. | Procedimiento para la purificacion a gran escala de plasmidos. |
US6011148A (en) * | 1996-08-01 | 2000-01-04 | Megabios Corporation | Methods for purifying nucleic acids |
US5707812A (en) | 1996-08-06 | 1998-01-13 | Vical Incorporated | Purification of plasmid DNA during column chromatography |
EP0853123A1 (de) * | 1997-01-10 | 1998-07-15 | Roche Diagnostics GmbH | Reinigung von DNA durch Cross-Flow-Filtration |
PT1944362E (pt) | 1997-09-05 | 2016-01-27 | Genzyme Corp | Métodos de produção de preparações de alto título de vetores aav recombinantes desprovidos de adjuvantes |
SE9703532D0 (sv) | 1997-09-30 | 1997-09-30 | Pharmacia Biotech Ab | A process for the purification of plasmid DNA |
AU4314099A (en) | 1998-06-01 | 1999-12-20 | Immune Response Corporation, The | Novel method of large scale plasmid purification |
US6268492B1 (en) | 1998-08-10 | 2001-07-31 | Chiron Corporation | Methods for purifying non-chromosomal nucleic acid molecules from cells |
-
2000
- 2000-07-21 DE DE60009912T patent/DE60009912T2/de not_active Expired - Fee Related
- 2000-07-21 JP JP2001512868A patent/JP2003505077A/ja active Pending
- 2000-07-21 CN CN00813109A patent/CN1378592A/zh active Pending
- 2000-07-21 KR KR1020027000915A patent/KR100669305B1/ko not_active IP Right Cessation
- 2000-07-21 EP EP00948876A patent/EP1200578B1/de not_active Expired - Lifetime
- 2000-07-21 US US09/620,849 patent/US6313285B1/en not_active Expired - Fee Related
- 2000-07-21 HU HU0202295A patent/HUP0202295A3/hu unknown
- 2000-07-21 IL IL14764400A patent/IL147644A0/xx unknown
- 2000-07-21 CA CA002378944A patent/CA2378944A1/en not_active Abandoned
- 2000-07-21 BR BR0012627-6A patent/BR0012627A/pt not_active IP Right Cessation
- 2000-07-21 AT AT00948876T patent/ATE264386T1/de not_active IP Right Cessation
- 2000-07-21 PL PL00364816A patent/PL364816A1/xx not_active Application Discontinuation
- 2000-07-21 PT PT00948876T patent/PT1200578E/pt unknown
- 2000-07-21 ES ES00948876T patent/ES2218185T3/es not_active Expired - Lifetime
- 2000-07-21 WO PCT/US2000/019963 patent/WO2001007599A1/en active IP Right Grant
- 2000-07-21 DK DK00948876T patent/DK1200578T3/da active
- 2000-07-21 NZ NZ516641A patent/NZ516641A/en unknown
-
2003
- 2003-02-12 HK HK03101013.8A patent/HK1048829A1/zh unknown
Also Published As
Publication number | Publication date |
---|---|
PT1200578E (pt) | 2004-08-31 |
JP2003505077A (ja) | 2003-02-12 |
IL147644A0 (en) | 2002-08-14 |
KR100669305B1 (ko) | 2007-01-17 |
US6313285B1 (en) | 2001-11-06 |
PL364816A1 (en) | 2004-12-13 |
EP1200578B1 (de) | 2004-04-14 |
NZ516641A (en) | 2003-07-25 |
HUP0202295A2 (en) | 2002-10-28 |
KR20020019123A (ko) | 2002-03-09 |
DK1200578T3 (da) | 2004-07-26 |
WO2001007599A1 (en) | 2001-02-01 |
CN1378592A (zh) | 2002-11-06 |
BR0012627A (pt) | 2002-04-09 |
ATE264386T1 (de) | 2004-04-15 |
ES2218185T3 (es) | 2004-11-16 |
DE60009912T2 (de) | 2005-04-14 |
CA2378944A1 (en) | 2001-02-01 |
HK1048829A1 (zh) | 2003-04-17 |
EP1200578A1 (de) | 2002-05-02 |
HUP0202295A3 (en) | 2005-01-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE60009912D1 (de) | Verfahren zur rnase- und organische lösemitteln-freier reinigung von plasmid-dns durch tangentialfluss-filtration | |
DK0851937T3 (da) | Fremgangsmåde til oprensning, stabilisering eller isolering af nucleinsyrer fra biologiske materialer | |
ATE236183T1 (de) | Verfahren zur reinigung von nukleinsäuren | |
ATE163043T1 (de) | Reinigungsmethode und entsprechende vorrichtung | |
DE69908795D1 (de) | Verfahren zur isolierung von nukleinsäure und vorrichtung hierfür | |
NO20063278L (no) | Hurtigfremstilling av nukleinsyrer ved enzymatisk fordoyelse | |
ATE247605T1 (de) | Verfahren zum biologischen reinigen von abwasser | |
CA2501308A1 (en) | Extraction of dna from biological samples | |
ATE243168T1 (de) | Verfahren und vorrichtung zur behandlung von abwasser in einem bioreaktor, einer ultrafiltrationseinheit und einer membranfiltrationeinheit | |
DK0894091T3 (da) | Fremgangsmåde til oprensning af et protein fra en proteinholdig opløsning | |
JPH04360686A (ja) | Dnaの精製方法 | |
EP0431905B1 (de) | Verfahren zur Reinigung von Phagen-DNA | |
DE60114048D1 (de) | Verfahren zur aufreinigung von maltose | |
EP1245674A3 (de) | Nukleinsäurereinigung | |
DK0833684T3 (da) | Fremgangsmåde til fjernelse af organiske bestanddele fra en vandig strøm | |
HK1042116A1 (zh) | 淨化或隔離過濾病毒核酸的方法 | |
WO2003057720A3 (en) | Recovery of biofilament proteins from biological fluids | |
AU2003288164A1 (en) | Method for treating radioactive waste water | |
ATE211117T1 (de) | Verfahren zur reinigung von alkalimetallsilikatlösungen | |
DE59700844D1 (de) | Verfahren zur Reinigung von O-Phthaldialdehyd | |
ATE522544T1 (de) | Verfahren zur gewinnung und reinigung von rekombinantem protein aus zellen | |
PT1102721E (pt) | Processo e dispositivo para separar biomassa e agua | |
CN111378649A (zh) | 一种高效洗涤液 | |
CN101532012B (zh) | 一种快速抽提纯化rna的试剂盒以及方法 | |
Di Napoli et al. | Recovery of hepatitis A virus and other enteroviruses from water samples |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8339 | Ceased/non-payment of the annual fee |